Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Minimal Residual Disease (MRD) in Multiple Myeloma

Share Button

“Overall survival was favorable among MRD-negative patients, as well as among patients with complete response.”

After 25 years and reading 000’s of studies, I’m cynical when it comes to conventional oncology and what they recommend about treating multiple myeloma. If an oncologist examined 21 studies and all they can come up with is/are words like favorable or associated with then minimal residual disease is no breakthrough.

If you are a newly diagnosed patient CR and MRD is certainly your goal for both your induction therapy as well as your autologous stem cell transplant should you decide to undergo this side-effect filled, toxic, grueling procedure. But I think that the MMers health and QOL must be balanced with the pursuit of either CR or MRD-negative status.

I am a long-term MM survivor and MM cancer coach. I read the study below two ways. Does reaching minimal residual disease (MRD) lead to longer overall survival in multiple myeloma no matter how much damage you do with chemotherapy?

Or are some types of myeloma prone to reaching MRD? Are their types of MM that are easier to kill than others? Could you reach minimal residual disease after having a short course of induction therapy?

Image result for pictures of minimal residual disease in hematologic malignancies

Further, are their evidence-based therapies that are cytotoxic to myeloma that are non-toxic? Are their evidence-based therapies that can enhance the efficacy of conventional chemotherapy regimens?

Yes and Yes. There are therapies that can integrate with conventional (FDA approved) chemotherapy. Combine RVD, for example, with evidence-based, non-toxic, anti-MM therapies such as supplementation, nutrition, bone health, lifestyle and mind-body therapies and your remission will be deeper, longer than it would with chemotherapy alone.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Click here to follow along with the Introduction Guide

Click here to get your FREE First Questions Guide


Have you been diagnosed with multiple myeloma? Are you experiencing any symptoms? Are you thinking about an autologous stem cell transplant (ASCT)?

Whether you are debating treatment options, currently undergoing treatment and experiencing painful side effects, or trying to figure out how to stay in remission, I want to share what I’ve learned from 22 years of full remission from Multiple Myeloma.

Have you been diagnosed with MM? Please scroll down the page, post a question or comment and I will reply to you ASAP.

thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


MRD-negative Status Linked With Better Survival in Multiple Myeloma

Minimal residual disease (MRD)-negative status among patients with newly-diagnosed multiple myeloma after treatment may be associated with long-term survival, according to a study published in JAMA Oncology.1

Researchers led by Nikhil Munshi, MD, of the Dana-Farber Cancer Institute in Boston, MA, evaluated 21 studies through Medline, which provided data on the impact of MRD status on progression-free and overall survival.

Information on patient characteristics, treatment, MRD assessment, and outcomes, were gathered. Data were adjusted to allow for different proportions of patients with MRD across the studies.

There were 12 studies with data on impact of MRD on overall survival, and 14 for progression-free survival. MRD-negative status was associated with better progression-free survival, particularly in studies of patients who had achieved conventional complete response.

Overall survival was favorable among MRD-negative patients, as well as among patients with complete response.”

Leave a Comment:

3 comments
Add Your Reply